Zeke Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.05M | Sell |
30,254
-3,140
| -9% | -$212K | 0.13% | 70 |
|
|
2022
Q3 | $1.66M | Hold |
33,394
| – | – | 0.12% | 84 |
|
|
2022
Q2 | $1.86M | Buy |
33,394
+3,930
| +13% | +$219K | 0.12% | 83 |
|
|
2022
Q1 | $1.64M | Buy |
29,464
+2,436
| +9% | +$135K | 0.08% | 102 |
|
|
2021
Q4 | $1.51M | Buy |
27,028
+1,470
| +6% | +$82.3K | 0.09% | 74 |
|
|
2021
Q3 | $1.23M | Hold |
25,558
| – | – | 0.07% | 86 |
|
|
2021
Q2 | $1.07M | Buy |
25,558
+1,894
| +8% | +$79.3K | 0.07% | 93 |
|
|
2021
Q1 | $798K | Sell |
23,664
-1,260
| -5% | -$42.5K | 0.06% | 100 |
|
|
2020
Q4 | $870K | Buy |
24,924
+5,164
| +26% | +$180K | 0.07% | 89 |
|
|
2020
Q3 | $686K | Buy |
19,760
+46
| +0.2% | +$1.6K | 0.08% | 83 |
|
|
2020
Q2 | $645K | Sell |
19,714
-35,348
| -64% | -$1.16M | 0.12% | 81 |
|
|
2020
Q1 | $1.66M | Sell |
55,062
-18,782
| -25% | -$565K | 0.47% | 28 |
|
|
2019
Q4 | $2.14M | Sell |
73,844
-116
| -0.2% | -$3.36K | 0.18% | 106 |
|
|
2019
Q3 | $1.91M | Buy |
73,960
+1,134
| +2% | +$29.3K | 0.17% | 103 |
|
|
2019
Q2 | $1.86M | Buy |
72,826
+2,652
| +4% | +$67.7K | 0.18% | 103 |
|
|
2019
Q1 | $1.84M | Buy |
70,174
+6,308
| +10% | +$165K | 0.17% | 105 |
|
|
2018
Q4 | $1.47M | Sell |
63,866
-193,652
| -75% | -$4.46M | 0.14% | 131 |
|
|
2018
Q3 | $6.07M | Buy |
257,518
+6,986
| +3% | +$165K | 0.5% | 39 |
|
|
2018
Q2 | $5.78M | Buy |
+250,532
| New | +$5.78M | 0.54% | 40 |
|